From: Tumor cell response to bevacizumab single agent therapy in vitro
 |  | NSCLC | CRC | RCC | BC |  | ||||
---|---|---|---|---|---|---|---|---|---|---|
 |  | H522 | HOP62 | HCT-116 | HT-29 | KM12 | A498 | HS-578 T | MDA-MB-231 | HUVEC |
Protein expression | VEGFR1 | - | + | - | + | - | + | + | + | + |
VEGFR2 | + | - | + | n.d. | - | - | - | + | + | |
NRP1 | + | + | + | + | + | + | + | + | - | |
Cell surface expression | VEGFR1 | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. |
 | VEGFR2 | - | - | - | - | - | - | - | + | + |
 | NRP1 | - | + | - | - | - | + | + | + | - |